XML 39 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue (Tables)
 9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents the approximate percentage of our net sales by market group:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
Biologics
41 %
40 %
39 %
38 %
Generics
 17 %
18 %
17 %
17 %
Pharma
22 %
23 %
25 %
25 %
Contract-Manufactured Products
20 %
19 %
19 %
20 %
100 %
100 %
100 %
100 %
The following table presents the approximate percentage of our net sales by product category:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
High-Value Product ("HVP") Components
48 %
45 %
47 %
46 %
High-Value Product ("HVP") Delivery Devices
12 %
16 %
13 %
12 %
Standard Packaging
20 %
20 %
21 %
22 %
Contract-Manufactured Products
20 %
19 %
19 %
20 %
100 %
100 %
100 %
100 %
The following table presents the approximate percentage of our net sales by geographic location:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
Americas
47 %
48 %
47 %
44 %
Europe, Middle East, Africa
45 %
44 %
45 %
47 %
Asia Pacific
8 %
8 %
8 %
9 %
100 %
100 %
100 %
100 %
Schedule of Change in Contract with Customer, Asset and Liability
The following table summarizes our contract assets and liabilities:
($ in millions)
Contract assets, December 31, 2024
$23.3 
Contract assets, September 30, 2025
27.5 
Change in contract assets - increase (decrease)$4.2 
Deferred income, December 31, 2024
$(53.2)
Deferred income, September 30, 2025
(47.3)
Change in deferred income - decrease (increase)$5.9